Continuous glucose monitors (CGMs) and insulin pumps can transform diabetes management, but the technology only works when patients can comfortably keep wearing it. CGM skin irritation can turn a valuable device into a daily source of itching, redness, pain, or damaged skin. In some cases, the reaction becomes severe enough …
Read More »Years After Bariatric Surgery, Blood Sugar Can Crash Without Warning. Here’s Why.
Blood glucose may improve dramatically after metabolic or bariatric surgery. Yet, for some patients, a very different glucose problem develops months or years later. Post-bariatric hypoglycemia can cause sudden drops in blood glucose after meals, with symptoms ranging from sweating and tremor to confusion, seizures, or loss of consciousness. Because …
Read More »Your Eye Exam May Be Predicting More Than Vision Loss: AI Is Finding Hidden Diabetes Risks
For people with diabetes, a retinal photograph has traditionally answered one major question: Is diabetic retinopathy developing? However, artificial intelligence is beginning to uncover much more. Emerging retinal AI models for systemic risk assessment can detect patterns associated with cardiovascular disease, kidney disease, blood pressure, and metabolic health. As a …
Read More »It’s Not Just About Sleep: How Circadian Medicine Could Rewrite Diabetes Care
Diabetes care has traditionally focused on what patients eat, how much they exercise, and which medications they use. However, a growing field adds another question: when do these things happen? Research into circadian medicine in diabetes care suggests that the body’s internal clock may influence insulin sensitivity, glucose tolerance, hormone …
Read More »LDL Is Under Control—So Why Is Heart Risk Still High? Solving the Lipoprotein(a) Puzzle
For many people with diabetes, lowering LDL cholesterol is a major part of preventing heart attack and stroke. Yet an important clinical puzzle remains. Why do some patients experience cardiovascular events even after LDL reaches recommended targets? Growing evidence points toward lipoprotein(a), or Lp(a), as one possible piece of that …
Read More »Your Insulin Pump Is Learning Your Habits: How AI Is Quietly Changing Diabetes Care
Artificial intelligence is entering diabetes care in a surprisingly quiet way. Rather than appearing as a chatbot or separate decision-support tool, increasingly sophisticated algorithms are being built into automated insulin delivery systems. Adaptive insulin pump hardware can work with continuous glucose monitor (CGM) data, recent insulin delivery, and changing glucose …
Read More »The Exercise Hormones That Could Become Tomorrow’s Diabetes Drugs
What if scientists could capture some of the metabolic benefits of exercise in a medicine? Research into the connection between myokines and diabetes is bringing that possibility closer to serious scientific discussion. When skeletal muscles contract, they do more than move the body. They release signaling molecules called myokines that …
Read More »Can Turning Body Fat Into a Metabolic Powerhouse Change Diabetes Treatment?
For decades, diabetes research has focused on protecting insulin-producing beta cells or replacing those that have been lost. However, scientists are now exploring a completely different strategy. Instead of repairing the pancreas, researchers are investigating whether the body’s own fat can become a powerful tool for improving glucose control. This …
Read More »Could Tiny RNA Molecules Transform the Future of Diabetes Care?
Diabetes research is moving beyond blood sugar measurements and insulin therapy into an exciting new frontier. One of the most promising areas involves microRNAs, tiny RNA molecules that quietly regulate hundreds of genes throughout the body. Although they are microscopic, their influence on insulin production, inflammation, and blood vessel health …
Read More »Your LDL Is Normal—So Why Is Your Heart Risk Still High?
For years, lowering LDL cholesterol has been the cornerstone of preventing heart disease in people with diabetes. Statins and other cholesterol-lowering therapies have dramatically reduced cardiovascular events. Yet many patients continue to experience heart attacks, strokes, or other cardiovascular complications despite reaching recommended LDL cholesterol goals. Why does this happen? …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.